Filter Results:
(3,612)
Show Results For
- All HBS Web
(6,830)
- People (18)
- News (2,177)
- Research (3,612)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,797)
Show Results For
- All HBS Web
(6,830)
- People (18)
- News (2,177)
- Research (3,612)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,797)
Sort by
- December 2014
- Case
DaVita HealthCare Partners and the Denver Public Schools: Creating Connections
By: John J-H Kim and Christine S. An
In 2011, DaVita HealthCare Partners (DaVita)—a Fortune 500 healthcare services company specializing in kidney dialysis services—and the Denver Public Schools (DPS)—the largest school district in Colorado—forged a plan to incorporate greater intentional focus on culture... View Details
Keywords: Corporate-community Partnerships; K-12; School Districts; DaVita; Kent Thiry; Tom Boasberg; Denver Public Schools; Wisdom Team; DaVita Way; Creating Connections; Social Enterprise; Community Impact; Education Reform; Public Schools; Leadership Development; Partners and Partnerships; Social Entrepreneurship; Education; Business and Community Relations; Culture; Education Industry; Education Industry; Colorado
Kim, John J-H, and Christine S. An. "DaVita HealthCare Partners and the Denver Public Schools: Creating Connections." Harvard Business School Case 315-047, December 2014.
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (D)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (D)." Harvard Business School Supplement 195-219, April 1995. (Revised August 1995.)
- November 2006 (Revised March 2008)
- Case
The Harvard Stem Cell Institute
Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how... View Details
Keywords: Talent and Talent Management; Higher Education; Entrepreneurship; Collaborative Innovation and Invention; Intellectual Property; Research and Development; Genetics; Biotechnology Industry; Biotechnology Industry; Massachusetts
Sahlman, William A. "The Harvard Stem Cell Institute." Harvard Business School Case 807-096, November 2006. (Revised March 2008.)
- September 2006 (Revised February 2007)
- Case
Timing of Option Grants at UnitedHealth Group (A)
Faced with press allegations that executives' stock options might have been backdated, the Board of UnitedHealth Group needs to determine whether its accounting for the options was proper, and if not, what the restatement amount should be and what... View Details
Keywords: Governing and Advisory Boards; Ethics; Stock Options; Accounting; Crisis Management; Corporate Governance; Insurance Industry; Insurance Industry; United States
Ferri, Fabrizio. "Timing of Option Grants at UnitedHealth Group (A)." Harvard Business School Case 107-028, September 2006. (Revised February 2007.)
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- February 1997 (Revised June 1999)
- Teaching Note
Massachusetts General Hospital: CABG Surgery (A) TN
Teaching Note for (9-696-015). View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
business has a role to play in addressing it." For example, in one video clip, Yusuf Hamied, chairman of Mumbai-based pharmaceutical company Cipla, comments, "I'm a firm believer that if you're in the health View Details
Keywords: by Julia Hanna
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
forthcoming Academy of Management Journal Ideological Misfit? Political Affiliation and Employee Departure in the Private-Equity Industry By: Bermiss, Y. Sekou, and Rory McDonald Abstract—Though organizations are increasingly active... View Details
Keywords: Sean Silverthorne
- 07 Feb 2012
- First Look
First Look: February 7
fairness within the industry. Coordinating conflicting programs requires a careful balance between equity and efficiency. In our work, we first develop a fairness metric to measure deviation from first-scheduled, first-served in the... View Details
Keywords: Sean Silverthorne
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Pharmaceutical Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 04 Sep 2001
- Lessons from the Classroom
Getting Back on Course
not currently in the full-time workforce. Many of the women who chose to leave their professional careers had approached Clark during his recent visits with alumni groups. They told him they felt disconnected from business and from HBS after leaving full-time work to... View Details
Keywords: by Martha Lagace
- April 2021 (Revised April 2021)
- Case
Project Restart: Deciding the Future of English Football
By: Nour Kteily and Deepak Malhotra
In March 2020, the English Premier League football (soccer) season was suspended partway through due to the COVID-19 pandemic. Two months later the season remained in limbo, with a looming deadline to decide whether to attempt to complete the season or curtail it—and... View Details
Keywords: COVID-19 Pandemic; Sports; Health Pandemics; Decision Making; Fairness; Values and Beliefs; Business and Stakeholder Relations; Motivation and Incentives; Outcome or Result; Perception; Negotiation; Sports Industry; United Kingdom
Kteily, Nour, and Deepak Malhotra. "Project Restart: Deciding the Future of English Football." Harvard Business School Case 921-050, April 2021. (Revised April 2021.)
- 11 May 2010
- First Look
First Look: May 11
United States, expanding coverage and regulating insurers. However, it was not clear that expanding coverage would resolve a longstanding dilemma of rising costs for insurance and care. As the Department of Health and Human Services... View Details
Keywords: Martha Lagace
- 24 Sep 2013
- First Look
First Look: September 24
Earnings Call By: Eccles, Robert G., and George Serafeim Abstract—One of the challenges companies claim to face in making sustainability a core part of their strategy and operations is that the market does not care about sustainability,... View Details
Keywords: Sean Silverthorne
- 22 Aug 2017
- First Look
First Look at New Research and Ideas, August 23
industrial production (Alfaro and Chen, 2014). Using a unique worldwide plant-level dataset that reports detailed location, ownership, and operation information for plants in over 100 countries, we construct a spatially continuous index... View Details
Keywords: Sean Silverthorne
- 17 Dec 2001
- Research & Ideas
Becoming the Next Real Estate Mogul
"There were a lot of eyes on that project," Palandjian said. "It was gratifying on many levels, particularly because we renovated the building to a proper use—it could have just as easily been turned into a health... View Details
- January 2009 (Revised July 2009)
- Case
Targanta Therapeutics: Hitting a Moving Target
By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Biotechnology Industry
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
modern industrial corporation encompasses a myriad of different software applications, which must work in concert to deliver functionality to end users. However, the increasingly complex and dynamic nature of competition in today’s... View Details
Keywords: Sean Silverthorne
- 30 Jun 2015
- First Look
First Look: June 30, 2015
underlying the ratings. Our tests examine whether these forms of disclosure reflect firms' real efforts to combat corruption or are cheap talk. We find that the ratings are related to enforcement and monitoring, country and industry... View Details
Keywords: Carmen Nobel
- 19 Jul 2011
- Research & Ideas
Rupert Murdoch and the Seeds of Moral Hazard
the food and apparel industries and the need to "secure" all elements of their production chain, most other industries have yet to recognize such a hazard. In the media business, news items require... View Details